Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001273

Drug Information
NameCholecalciferol    
SynonymsVigorsan; NCGC00159331-02; MolPort-003-666-021; AB1002422; KBio2_004211; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; D3-Vigantol; C9756_SIGMA; Oleovitamin D3; Spectrum4_001201; KBio2_001643; Bio-0845; Colecalciferol; 1406-16-2; NSC375571; LS-825; CC; CID7251172; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol; AC1OIEWB; KBio3_001628; KBio2_006779; CID11463269; EINECS 215-797-2; CHEMBL1042; 25(OH)D; Colecalciferolo; Arachitol; Micro-dee; 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-; AC1OF2GL; Cholecalciferol [USAN:BAN:JAN]; I05-0041; 9,10-Secocholestr-5,7,10(19)-trien-3-ol,3-.beta.,5Z,7E-; HMS2092M12; Prestwick0_000429; Calciol; CID10340013; Cholecalciferol (D3); KBioSS_001643; NCGC00178668-01; LMST03020220; AC1O5EOF; CID7067440; Cholecalciferolum; Colecalciferolum; AC1LU7IZ; Spectrum3_000764; ()-Vitamin D3; 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol; Colecalciferolo [DCIT]; CID10045875; VITAMIN D3 POWDER; Prestwick2_000429; CID6221; UNII-1C6V77QF41; LMST03020221; 8050-67-7; Ebivit; C1357_SIAL; NEO Dohyfral D3; NCGC00017328-01; CID1548921; HMS1569E20; 89193_FLUKA; Vitinc Dan-Dee-3; CID10000117; DB00169; CHEBI:283119; CID7067439; BSPBio_002408; CID11014566; Prestwick1_000429; BSPBio_000418; NSC-375571; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; AC1O7GQ3; SpecPlus_000180; AC1NR2UU; 9,10-Secocholestra-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-; Ricketon; Spectrum_001163; AC1O7GAV; CID10883523; 7-Dehydrocholestrol, activated; Provitina; NSC 375571; LT00244775; (+)-Vitamin D3; 7-Dehydrocholesterol activated; Activated 7-dehydrocholesterol; AC1OIEW5; CID11058152; CCRIS 6286; UPCMLD-DP152:001; NCGC00016301-01; CID6992015; Activated 7-dehydrocholesterol; Colecalciferol (INN); Vitamin D3 emulsifiable; ZINC04492878; CID2735; CID5280795; CID6992016; AC1OF2GI; SPBio_002357; Spectrum2_001369; 57651-82-8; KBioGR_001602; Cholecalciferol, D3; ZINC04474460; Colecalcipherol; EINECS 200-673-2; cholecalciferol; CID6604201; SMP1_000068; LMST03020001; CID5353527; CID5283710; NCGC00159331-04; Delta-D (TN); MolPort-001-740-051; SPBio_001298; NCGC00179565-01; MolPort-001-785-972; vitamin d-3; CID11025493; Rampage; SR-05000001559; ZINC04492874; ZINC04492876; TNP00266; Delta-D; BPBio1_000460; CID10894379; (+)-Vitamin D3; MolPort-004-946-964; NCGC00179565-02; Trivitan; C9774_SIAL; ACon1_001997; C05443; CID5283711; CHEBI:28940; bmse000507; VITAMIN_D3; Delsterol; (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; Vitamin D3; LMST03020219; 47763_SUPELCO; LS-1570; KBio1_001220; VITAMIN D; NCGC00142511-01; AC1L1M23; Provitamine; ST057172; CID9821465; ZINC04492875; D3-Vicotrat; AC1NSHJX; 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol; Colecalciferolum [INN-Latin]; AC-11697; CID6604662; CHEMBL432780; 7-Dehydrocholesterol activated; Prestwick_63; 67-97-0; CID5283712; AC1L1ECK; D00188; Duphafral D3 1000; CID7251174; SR-05000001559-3; Irradiated 7-dehydrocholesterol; Deparal; C27H44O; CID6708595; AC1NR2UO; (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol; EPA Pesticide Chemical Code 202901; 8024-19-9; NCGC00091072-01; CID6432644; DivK1c_006276; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol; CCRIS 5813; AC1NS4AJ; CID6713938; CID5363362; Prestwick3_000429; FeraCol; AC1NR2UR; MEGxm0_000458; 7-Dehydrocholesterol, Activated; CAS-67-97-0; UPCMLD-DP152; Vi-de-3-hydrosol; AC1O8PWJ; AC1NQXLN; HSDB 820; Cholecalciferol (JP15/USP); AC1O8FEU; 7-Dehydrocholesterol, irradiated    
IndicationVitamin D deficiencyApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassVitamins    
CAS NumberCAS 67-97-0
FormularC27H44O    
PubChem Compound IDCID 6221.    
PubChem Substance IDSID 29225219.    
ChEBI28940;    
SuperDrug ATC IDA11CC05;    
SuperDrug CAS ID000067970;    
TargetVitamin D receptorBinder[2][3][4]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 021762 To Reference
Ref 2Vitamin D2 or vitamin D3?. Rev Med Interne. 2008 Oct;29(10):815-20. Epub 2008 Apr 11. To Reference
Ref 3Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Braz J Med Biol Res. 2009 Apr;42(4):312-22. To Reference
Ref 4Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004 Dec;80(6 Suppl):1689S-96S. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543